Notable regulatory approvals of emerging technologies over the past 30 days

Along with AI in its various iterations, the list may include virtual and augmented reality, 3D printing, robotics and other technologies currently changing healthcare delivery.

Interventional Systems: FDA clearance for robotic surgical instrument assistant (June 29)

Neuros Medical: FDA breakthrough designation for high-frequency pain blocking (June 29)

Cibiltech: CE mark for AI kidney transplant management (June 30)

Viz.ai: Ce mark for AI stroke-care coordination (June 30)

DeepLook: FDA clearance for deterministic lesion segmentation and measurement (July 8)

EnsoData: Expanded FDA clearance for AI sleep care (July 14)

Omniscient Neurotechnology: FDA clearance for digital brain mapping (July 21)

Asensus Surgical: FDA clearance for articulating robotic surgery instruments (July 28)

Medtronic: FDA clearance for AI cardiac monitoring (July 28)

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Heartflow, known for its AI-based CCTA evaluations, appears to be going public. The news follows years of momentum for the California-based company, including improved Medicare reimbursements for cardiac CT and a new Category I CPT code for its Plaque Analysis software.

Suman Tandon, MD, an American Society of Nuclear Cardiology board member, explains the group's call on Congress to update a number of healthcare policies. 

The 2026 MPFS proposed rule includes higher conversion factors across the board. However, some cardiology groups remain concerned about a series of reimbursement reductions for high-value cardiology services.